on September 22, 2005
Published online before print September 22, 2005, doi: 10.1161/01.STR.0000182100.65262.46
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on November 2, 2004
From the University of California (J.L.S.), Los Angeles; and Hospital Universitar Vall d’Hebron (C.M.), Barcelona, Spain. * To whom correspondence should be addressed. E-mail: jsaver{at}ucla.edu.
Background and Purpose--Reperfusion is the most beneficial of all therapeutic strategies for acute ischemic stroke. However, the standard cerebral reperfusion treatment of the first decade of the reperfusion era, noncontrast computed tomography (CT)-guided, Summary of Review--Innovative intravenous pharmacological reperfusion strategies include novel fibrinolytic agents (tenecteplase, reteplase, desmetolplase, plasmin, and microplasmin), glycoprotein (GP) IIb/IIIa antagonists with platelet disaggregating effects (abciximab and tirofiban), combination therapies to improve efficacy of clot lysis (fibrinolytics and GP IIb/IIIa agents, and fibrinolytics and direct thrombin inhibitors), increase the time window for clot lysis (fibrinolytics and neuroprotectants), and reduce the frequency of hemorrhagic complications (fibrinolytics and vasoprotectants), and externally applied ultrasound to enhance enzymatic fibrinolysis. Promising intra-arterial pharmacological reperfusion approaches include novel fibrinolytic agents, combined intravenous and intra-arterial fibrinolysis, and combined fibrinolytics and GP IIb/IIIa agents. Emerging endovascular mechanical reperfusion strategies include intra-arterial thrombectomy (clot retrieval devices and suction thrombectomy devices), mechanical disruption (micro-guidewire passage, laser photoacoustic emulsification, and primary intracranial angioplasty), and augmented fibrinolysis by endovascular ultrasound. Multimodal imaging, with magnetic resonance (MR) or CT, can rapidly assess infarct core, penumbra, site of vessel occlusion, and tissue hemorrhagic propensity, enabling improved selection of patients for reperfusion therapy beyond any arbitrary fixed time window. Conclusions--Therapeutic reperfusion is emerging as a treatment strategy of remarkable power and scope for rescuing patients experiencing acute brain ischemia, applicable within and beyond the 3-hour time window.
Revised on February 23, 2005
Accepted on April 21, 2005
Extending Reperfusion Therapy for Acute Ischemic Stroke. Emerging Pharmacological, Mechanical, and Imaging Strategies
Carlos A. Molina MD and Jeffrey L. Saver MD*
3 hours, intravenous tissue plasminogen activator, has many limitations. This review surveys emerging strategies that have the potential to extend cerebral reperfusion therapy to larger numbers of patients.
Key words: endovascular therapy • reperfusion • stroke, acute • thrombolysis
This article has been cited by other articles:
 |
|
 |
|
  R.G. Nogueira, L.H. Schwamm, and J.A. Hirsch Endovascular Approaches to Acute Stroke, Part 1: Drugs, Devices, and Data AJNR Am. J. Neuroradiol., April 1, 2009; 30(4): 649 - 661. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Saver Intra-Arterial Fibrinolysis for Acute Ischemic Stroke: The Message of Melt Stroke, October 1, 2007; 38(10): 2627 - 2628. [Full Text] [PDF]
|
|
|
|
|
|
N. Henninger and M. Fisher Stimulating Circle of Willis Nerve Fibers Preserves the Diffusion-Perfusion Mismatch in Experimental Stroke Stroke, October 1, 2007; 38(10): 2779 - 2786. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Hackney Does MR Imaging Improve Precision in Stroke Thrombolysis Trials? Radiology, August 1, 2007; 244(2): 323 - 324. [Full Text] [PDF]
|
|
|
|
 |
|
 H. P. Adams Jr, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, et al. Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation, May 22, 2007; 115(20): e478 - e534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. P. Adams Jr, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, et al. Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists Stroke, May 1, 2007; 38(5): 1655 - 1711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-H. Rha and J. L. Saver The Impact of Recanalization on Ischemic Stroke Outcome: A Meta-Analysis Stroke, March 1, 2007; 38(3): 967 - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Baker, V. Sica, L. M. Work, S. Williams-Ignarro, F. de Nigris, L. O. Lerman, A. Casamassimi, A. Lanza, C. Schiano, M. Rienzo, et al. Brain protection using autologous bone marrow cell, metalloproteinase inhibitors, and metabolic treatment in cerebral ischemia PNAS, February 27, 2007; 104(9): 3597 - 3602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. J. Marder, D. J. Chute, S. Starkman, A. M. Abolian, C. Kidwell, D. Liebeskind, B. Ovbiagele, F. Vinuela, G. Duckwiler, R. Jahan, et al. Analysis of Thrombi Retrieved From Cerebral Arteries of Patients With Acute Ischemic Stroke Stroke, August 1, 2006; 37(8): 2086 - 2093. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Saver Does the Merci Retriever Work?: For Stroke, May 1, 2006; 37(5): 1340 - 1341. [Full Text] [PDF]
|
|